Cardiovascular Innovation Institute

The Cardiovascular Innovation Institute (CII) is a collaborative research enterprise between the University of Louisville and UofL Health, dedicated to the development of advanced cardiovascular technologies. The institute focuses on a broad spectrum of innovation, ranging from basic discovery to clinical implementation of medical devices and regenerative medicine. Key areas of expertise include the development of total artificial hearts, ventricular assist devices, and the use of adipose-derived cell therapies for cardiac repair. CII operates state-of-the-art facilities that support bio-printing, cell isolation, and preclinical testing of cardiovascular interventions. By bridging the gap between engineering and medicine, the institute aims to provide transformative solutions for patients with end-stage heart failure and other cardiovascular conditions.